LexDanaLexDanabeta
Inventor

Klaus Schiene

Inventor
Juechen, DE

Overview

55→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes26%
C07CAcyclic or carbocyclic compounds5%
C07KPeptides1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
10,829,4803-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives202010,813,891Method of inhibiting chronification of pain202010,813,890Pharmaceutical combination202010,807,9893-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives202010,471,079Combination of selected analgesics and COX-II inhibitors201910,398,657Method of inhibiting chronification of pain201910,206,890Pharmaceutical combination201910,076,510Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative20189,855,286'Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component'20189,771,359'Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II'20179,624,209'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20179,320,729'Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative'20169,308,196'Pharmaceutical composition comprising (1 r,4r) -6\'-fluoro-N ,N-dimethyl-4-phenyl-4\',9\'-d ihydro-3\'H-spiro[cyclohexane-1,1\'-pyrano-[3,4,b]indol]-4-amine and an oxicam'20169,120,756'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20158,946,204'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20158,912,226'Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR'20148,846,765'Pharmaceutical combination'20148,791,268'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions'20148,785,474'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions'20148,735,426'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions'20148,710,233'Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations'20148,642,623'Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions'20148,642,775'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions'20148,618,177'Method of treating pain caused by inflammation'20138,592,471'Substituted phenylureas and phenylamides as vanilloid receptor ligands'20138,580,965'Substituted sulfonamide compounds'20138,541,573'Substituted sulfonamide compounds'20138,435,978'Substituted sulfonamide compounds'20138,420,691'Combination of selected analgesics and COX-II inhibitors'20138,404,749'Method of inhibiting inflammatory pain'20138,367,700'Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators'20138,334,315'Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands'20128,318,769'Substituted sulfonamide compounds'20128,318,774'Compounds involving mGluR5 receptor regulation and methods of making the compounds'20128,278,338'Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety'20128,252,816'Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions'20128,084,484'Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions'20118,084,470'Substituted nicotinamide compounds and uses thereof'20118,017,772'Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain'20118,008,304'Substituted propiolic acid amides and their use for producing drugs'20118,003,701'Method of inhibiting inflammatory pain'20117,893,069'Substituted imidazo[2,1-b]thiazole compounds and uses thereof'20117,879,858'Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions'20117,879,991'CGRP binding nucleic acids'20117,871,999'Substituted thiazoles and their use for producing drugs'20117,858,613'Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs'20107,786,160'Combination of selected analgesics and COX-II inhibitors'20107,754,754'Pharmaceutical formulations containing substituted 2 heteroarylaminoacetic acid compounds'20107,625,900'Sutstituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain'20097,432,296'Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds'20087,420,056'Substituted bicyclic imidazo-3-ylamine compounds'20087,384,961'Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants'20087,342,133'Substituted amino compounds as 5-HT/NA uptake inhibitors'20087,300,939'Substituted 1-propiolylpiperazine compounds, their preparation and use'20077,109,214'Substituted cyclopentene compounds'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2014Based in Düsseldorf, DE· patent location history
2007–2020Patents assigned to GRUENENTHAL GMBH (50)· patent assignee history
2007–2019Based in Duesseldorf, DE· patent location history
2011–2015Patents assigned to SCHIENE KLAUS (23)· patent assignee history
2011–2015Patents assigned to BAHRENBERG GREGOR (13)· patent assignee history
2011–2015Patents assigned to CHRISTOPH THOMAS (13)· patent assignee history
2011–2015Patents assigned to DE VRY JEAN (13)· patent assignee history
2011–2020Based in Juechen, DE· patent location history
2011–2017Based in Jüchen, DE· patent location history
2011–2012Based in Juchen, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GRUENENTHAL GMBH502007–2020
SCHIENE KLAUSself232011–2015
BAHRENBERG GREGOR132011–2015
CHRISTOPH THOMAS132011–2015
DE VRY JEAN132011–2015
Locations
LocationPatentsSpan
Juechen, DE272011–2020
Duesseldorf, DE192007–2019
Düsseldorf, DE42006–2014
Jüchen, DE32011–2017
Juchen, DE22011–2012